TD Cowen reiterates Mirum Pharmaceuticals stock Buy rating at $140

Baird reiterates Mirum Pharmaceuticals stock rating on trial success

Investing.com · News 9m ago

RBC raises ServiceNow stock price target on AI momentum

Investing.com · News 9m ago

RBC raises Atlassian stock price target on subscription growth outlook

Investing.com · News 9m ago

OIA Ex-Dividend Reminder - 10/14/26

NASDAQ · Markets 11m ago

Earnings call transcript: ICICI Prudential AMC posts strong Q2 2026 growth

Investing.com · News 11m ago

Doubleline Income Solutions Fund About To Put More Money In Your Pocket (DSL)

NASDAQ · Markets 11m ago

Cash Dividend On The Way From Virtus Diversified Income & Convertible Fund (ACV)

NASDAQ · Markets 11m ago

Stock Market Warning Signal Seen Only 5 Times Since 1871 Points to Serious Downside Risk

NASDAQ · Markets 12m ago

Stifel reiterates Hold on Kontoor Brands stock, $80 target maintained

Investing.com · News 15m ago

RBC Capital reiterates Mirum Pharmaceuticals stock rating on trial data

Investing.com · News 15m ago